- Total Pro Portfolios with ELGX:
- Defiance Asset Management
- show more
- 1
- Total Do-It-Yourself Portfolios with ELGX:
- Just trying to make a buck
- Copper
- Outperformers
- crhammer Portfolio 1
- gabrielmd Portfolio 1
- pwobbe Portfolio 1
- S-0037
- Barron's Activist Stocks 10-18-2008
- 200907 Gorongo Value
- show more
- 17
- Culann Smith Portfolio 1
- dgh_all
- ou82much Portfolio 1
- SUPRATRADE THURSDAY PICK IV
- Louie0220 Portfolio 1
- SUPRATRADE "SELL IT ALL TODAY" (25.august)
- healthcare and staples
- Barron's Activist Stocks 6-13-2009
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:Gorongo |
Date:07 09 09 |
Growth and resistence to change in healthcare ind |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:10 18 08 |
A group including Elliott Associates is prepared to offer to acquire all of Endologix's outstanding stock for $2.25 a share. Elliott said that it thinks highly of the company and John McDermott, its new chief executive. Endologix designs and markets minimally invasive products to treat vascular problems. The private-equity firm said that it wants to grow the company "into the successful business we believe it should be." The Elliott group holds 6,332,665 shares (14.5% of the total outstanding). |
|
Not yet rated
Rate now:
|
|
By:supratrade |
Date:04 05 07 |
Ratings change: buy, Price target: USD 5 |
|
Not yet rated
Rate now:
|
|
By:Dennis Howe |
Date:01 23 07 |
LT spec |
|
Not yet rated
Rate now:
|
|
By:Tom Ferris |
Date:01 03 07 |
new product |
|
Not yet rated
Rate now:
|
|
By:Pam |
Date:11 30 -1 |
From: Just Trying to make a Buck: |
|
Not yet rated
Rate now:
|
|
By:Deamiter |
Date:11 30 -1 |
Ramping up number of sales representatives right when they're likely to get their product covered by Government health insurance. Also makes the only comparable stent that's under review in Japan (as far as I know). |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |








